Third Biennial Symposium on Biology, Diagnosis and Treatment of Lymphomas

The Abramson Cancer Center of the University of Pennsylvania
Last Modified: August 15, 2005

Share article

Conference Dates: Friday, October 14, 2005
Conference Location: Marriott West, West Conshohocken, PA

Sponsoring Group: Abramson Cancer Center of the University of Pennsylvania

Conference Brochure: Download PDF version of conference brochure.

Topics Covered: Non-Hodgkins, Hodgkins, Prognostic Markers, New Targeted Therapies

Conference Objectives: At the completion of this conference, participants should be able to:

  1. Discuss the current classification of lymphomas as well as the controversies in diagnosis and their impact on management;
  2. Gain new insight into pathogenesis of lymphomas;
  3. Appreciate the growing role of understanding the basic mechanisms of the disease in diagnosis and treatment of lymphomas;
  4. Critically assess novel diagnostic and therapeutic approaches to lymphomas

Who Should Attend: Clinical Oncologists, Pathologists, Hematopathologists, Oncology Nurses and other health care professional involved in the treatment of patients with lymphoma

Conference Agenda:

  • Welcome and Introduction: John Glick
  • Classification of lymphomas: Dale Frank
  • Biology of non-Hodgkin’s lymphomas: diagnostic and therapeutic implications: Mariusz A. Wasik
  • Biology of Hodgkin lymphoma: Harald Stein (Free Univ. Berlin) 9:40- 9:55 Questions and Answers
  • Proteomic analysis of aberrant cell signaling in lymphomas: Kojo Elenitoba-Johnson (Univ. of Utah)
  • Prognostic markers in small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL): Adam Bagg
  • siRNA expression profile of SLL/CLL: Carlo Croce (Ohio State)
  • Glucose metabolism by lymphoma cells: diagnostic and therapeutic implications: Rebecca Ellstrom (Univ. of Michigan)
  • Antibody-based therapy of lymphomas: John Leonard (Weill/Cornell)
  • Histone deactehylase inhibitors in treatment of lymphomas: Ellen Kim
  • Targeted therapies for SLL/CLL: John Byrd (Ohio State)
  • Targeted therapies for non SLL/CLL small B-cell lymphomas: Stephen Schuster
  • New therapeutic agents for aggressive B-cell lymphoma: Sunita Nasta
  • Closing remarks: Mariusz Wasik/Stephen Schuster

Registration Information: For more information, or to request a brochure, please contact Mary Graham at 215-662-7328 or

Conference Fees: $175.00 physician, $95.00 nurses and other health care professionals, No fee for faculty, staff, fellows & students of the University of Pennsylvania

Online Registration
All fields are required.

First Name:
Last Name:
Email Address:
Academic Degree:
Medical Specialty:
(Hospital, Office, Company)

( Affiliation Home)
State   ZIP Code:
Daytime Telephone #:
Fax #:
Registration: $175 - Physicians
   Credit Card

$95 - Nurses & other health care professionals
   Credit Card

Free - faculty, staff, fellows & students of the University of Pennsylvania


Make checks payable to: Trustees, University of Pennsylvania. Mail payment and registration to:

Mary Graham
Abramson Cancer Center of the University of Pennsylvania
3400 Spruce St. - 16 Penn Tower
Philadelphia, PA 19104-4283
P: 215-662-7328 • F: 215-614-1854

Continuing Education: Yes. The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

JAK3 Mutations ID'd in About One-Third of T-Cell Lymphomas

Jun 18, 2012 - Approximately one-third of patients with natural killer/T-cell lymphoma (NKTCL) harbor somatic-activating Janus kinase 3 (JAK3) mutations, according to a study published online June 15 in Cancer Discovery.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More